Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design (Q80969523)
Jump to navigation
Jump to search
scientific article published on 02 August 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design |
scientific article published on 02 August 2007 |
Statements
Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design (English)
Claus G Roehrborn
Jack Barkin
Ronaldo Damiao
Marek Wyczolkowski
Annette Duggan
Kim Major-Walker
Betsy B Morrill
CombAT study group